Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

Abstract

Models for introducing new drugs are essential to optimize their prescribing especially where there are concerns. Without such models, new drugs may be withdrawn prematurely and/or struggle for funding.